NorthWest Biotherapeutics Inc (NWBO)

[gnawkz]

I think AngeloFoca was trying to indicate that the difference in cash is the number 1 reason why CLDX is so much farther on their trial.

Recent evidence of trial sites opening also show that more funding = FAR better enrollment.

If it wasn't so difficult for NWBO to get funding last year with all of AF's attacks, we would be in a far better position.

Another important aspect is that banks have been cut out of the most recent deal. The House should never be left out of a deal, and they were left out of the $40 MM funding round.